已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Targeting MEK in a Translational Model of Histiocytic Sarcoma

作者
Marilia Takada,Jeremy M.L. Hix,Sarah M. Corner,Peter Z. Schall,Matti Kiupel,Vilma Yuzbasiyan‐Gurkan
出处
期刊:Molecular Cancer Therapeutics [American Association for Cancer Research]
卷期号:17 (11): 2439-2450 被引量:37
标识
DOI:10.1158/1535-7163.mct-17-1273
摘要

Abstract Histiocytic sarcoma in humans is an aggressive orphan disease with a poor prognosis as treatment options are limited. Dogs are the only species that spontaneously develops histiocytic sarcoma with an appreciable frequency, and may have value as a translational model system. In the current study, high-throughput drug screening utilizing histiocytic sarcoma cells isolated from canine neoplasms identified these cells as particularly sensitive to a MEK inhibitor, trametinib. One of the canine cell lines carries a mutation in PTPN11 (E76K), and another one in KRAS (Q61H), which are associated with the activation of oncogenic MAPK signaling. Both mutations were previously reported in human histiocytic sarcoma. Trametinib inhibited sensitive cell lines by promoting cell apoptosis, indicated by a significant increase in caspase 3/7. Furthermore, in vitro findings were successfully recapitulated in an intrasplenic orthotopic xenograft mouse model, which represents a disseminated aggressive form of histiocytic sarcoma. Mice with histiocytic sarcoma xenograft neoplasms that were treated with trametinib had significantly longer survival times. Target engagement was validated as activity of ERK, downstream of MEK, was significantly downregulated in neoplasms of treated mice. Additionally, trametinib was found in plasma and neoplastic tissues within projected therapeutic levels. These findings demonstrate that in dogs, histiocytic sarcoma may be associated with a dysfunctional MAPK pathway, at least in some cases, and may be effectively targeted through MEK inhibition. Clinical trials to test safety and efficacy of trametinib in dogs with histiocytic sarcoma are warranted, and may provide valuable translational information to similar diseases in humans. Mol Cancer Ther; 17(11); 2439–50. ©2018 AACR.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
FashionBoy的应助被listen采纳,获得10
刚刚
xiankanyun发布了新的文献求助10
1秒前
3秒前
情怀的应助被李洪杰采纳,获得10
3秒前
开心香岚发布了新的文献求助10
4秒前
美满的诗蕾完成签到,获得积分10
5秒前
海洋完成签到 ,获得积分10
5秒前
丘比特的应助被清脆的静曼采纳,获得10
5秒前
沙漏的回忆完成签到 ,获得积分10
6秒前
6秒前
Clay完成签到 ,获得积分10
6秒前
慕青的应助被richardhipower采纳,获得10
8秒前
yangpeiyao完成签到,获得积分10
8秒前
tao_ht完成签到,获得积分20
9秒前
开心香岚完成签到,获得积分10
9秒前
9秒前
gfydsl发布了新的文献求助20
10秒前
小豆包发布了新的文献求助10
10秒前
10秒前
虚心发布了新的文献求助10
11秒前
结实的鸵鸟完成签到 ,获得积分10
11秒前
fdwonder完成签到,获得积分0
11秒前
Tom完成签到,获得积分10
11秒前
落寞绝音完成签到,获得积分10
11秒前
冰糖完成签到 ,获得积分10
11秒前
13秒前
13秒前
13秒前
13秒前
14秒前
Moonlight完成签到 ,获得积分10
14秒前
悠悠球完成签到,获得积分10
14秒前
落寞绝音发布了新的文献求助10
14秒前
vetzlk完成签到 ,获得积分10
15秒前
15秒前
16秒前
luocan发布了新的文献求助10
16秒前
16秒前
六边形猪宝完成签到 ,获得积分10
17秒前
蔚欢完成签到 ,获得积分0
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189866
求助须知:如何正确求助?哪些是违规求助? 9577019
关于积分的说明 21851254
捐赠科研通 7787798
什么是DOI,文献DOI怎么找? 3435795
关于科研通互助平台的介绍 2559856
邀请新用户注册赠送积分活动 2482699